Magaldrate 400mg, Simethicone 20mg & Oxetacaine 10mg Oral Suspension (per 5ml) — Oral Liquids
WHO-GMP Certified Commercial Pack · Product Code: AKP-036

Magaldrate 400mg, Simethicone 20mg & Oxetacaine 10mg Oral Suspension (per 5ml)

Formulation Overview: Topical mucosal anaesthetic-fortified antacid suspension providing instant local numbing relief from acute gastric burning while neutralizing acid and eliminating entrapped gas. Formulated with Magaldrate IP 400 mg + Simethicone IP 20 mg + Oxetacaine BP 10 mg (400 mg + 20 mg + 10 mg / 5 ml) in Oral Antacid & Anaesthetic Suspension dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 170 ml / 200 ml Amber PET Bottle with Dosing Cap with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-036
Therapeutic SectorGastroenterology & PPIs
Dosage FormOral Antacid & Anaesthetic Suspension
Active IngredientMagaldrate IP 400 mg + Simethicone IP 20 mg + Oxetacaine BP 10 mg
Strength / Purity400 mg + 20 mg + 10 mg / 5 ml
Clinical IndicationSevere painful esophagitis, acute gastritis, peptic ulcer pain, and reflux-induced throat burn
Specification StandardIP / BP / USP Compendial
Packaging Format170 ml / 200 ml Amber PET Bottle with Dosing Cap
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; shake well before use; do not freeze
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Oral Liquids & Gastroenterology & PPIs